Form 13-F position report

IDEAYA BIOSCIENCES INC

Reported by Sio Capital Management LLC

IDYA CUSIP 45166A102 Manager CIK 0001482416

Reported 500,117 shares, up 19,734 (4.1%) from the prior quarter.

Reported value 7.3%; share count 4.1% vs. the prior quarter.

Added
% of reported 13F value 3.64% This manager · Q3 2026
Shares 500,117 Quarter-end amount reported
Reported value $19,214,495 Fair value at quarter end
Consecutive quarters held 17 Through Q3 2026

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2022-09-30 1044000
2022-12-31 1271900
2023-03-31 961100
2023-06-30 1752959
2023-09-30 1996709
2023-12-31 1174389
2024-03-31 1448347
2024-06-30 0
2024-09-30 3896640
2024-12-31 3161100
2025-03-31 2014740
2025-06-30 2611315
2025-09-30 3380298
2025-12-31 2617986
2026-03-31 0
2026-06-30 17903874
2026-09-30 19214495

Quarterly position history

How this manager's reported quarter-end position changed over time.

17 quarters
Quarterly reported position history for IDEAYA BIOSCIENCES INC held by Sio Capital Management LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2026 Added 500,117 +19,734 (4.1%) 3.64% $19,214,495 2026-11-16
Q2 2026 New 480,383 +480,383 (0.0%) 2.96% $17,903,874 2026-08-14
Q1 2026 Reduced 0 -75,730 (-100.0%) 0 $0 2026-05-14
Q4 2025 Reduced 75,730 -48,500 (-39.0%) 0.41% $2,617,986 2026-02-17
Q3 2025 Unchanged 124,230 0 (0.0%) 0.86% $3,380,298 2025-11-13
Q2 2025 Added 124,230 +1,230 (1.0%) 1.0% $2,611,315 2025-08-13
Q1 2025 Unchanged 123,000 0 (0.0%) 0.6% $2,014,740 2025-05-15
Q4 2024 Unchanged 123,000 0 (0.0%) 0.89% $3,161,100 2025-02-14
Q3 2024 New 123,000 +123,000 (0.0%) 1.55% $3,896,640 2024-11-14
Q2 2024 Reduced 0 -33,007 (-100.0%) 0 $0 2024-08-14
Q1 2024 Unchanged 33,007 0 (0.0%) 0.43% $1,448,347 2024-05-15
Q4 2023 Reduced 33,007 -41,000 (-55.4%) 0.27% $1,174,389 2024-02-13
Q3 2023 Reduced 74,007 -587 (-0.8%) 0.62% $1,996,709 2023-11-14
Q2 2023 Added 74,594 +4,594 (6.6%) 0.45% $1,752,959 2023-08-14
Q1 2023 Unchanged 70,000 0 (0.0%) 0.48% $961,100 2023-05-12
Q4 2022 Unchanged 70,000 0 (0.0%) 0.47% $1,271,900 2023-02-13
Q3 2022 New 70,000 +70,000 (0.0%) 0.33% $1,044,000 2022-11-14
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

312 managers reported IDEAYA BIOSCIENCES INC for Q3 2026.

Managers reporting IDEAYA BIOSCIENCES INC in Q3 2026.
Manager Activity Shares Change % of reported 13F Reported value Tenure
FMR LLC Added 14,472,529 +363,098 0.02% $556,034,570 23 qtrs
BlackRock Inc Added 9,548,534 +655,274 < 0.01% $366,854,656 9 qtrs
JANUS HENDERSON GROUP PLC Added 8,622,814 +1,357,561 0.14% $331,400,321 1 qtr
Capital Research Global Investors Reduced 5,340,938 -3,763 0.03% $205,198,838 14 qtrs
BAKER BROS ADVISORS LP Unchanged 5,010,030 0 0.91% $192,485,353 17 qtrs
VANGUARD CAPITAL MANAGEMENT LLC Added 4,311,706 +179,060 < 0.01% $165,655,745 3 qtrs
STATE STREET CORPORATION Reduced 3,927,715 -621,196 < 0.01% $150,902,810 26 qtrs
Logos Global Management LP Reduced 2,850,000 -150,000 5.9% $109,497,000 21 qtrs
ADAGE CAPITAL PARTNERS GP L L C Unchanged 2,715,391 0 0.15% $104,325,322 23 qtrs
GEODE CAPITAL MANAGEMENT LLC Added 2,544,717 +119,115 < 0.01% $97,785,437 26 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2026
Filed
November 16, 2026
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
500,117
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.